1175 related articles for article (PubMed ID: 23663741)
1. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
4. FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.
BonDurant LD; Ameka M; Naber MC; Markan KR; Idiga SO; Acevedo MR; Walsh SA; Ornitz DM; Potthoff MJ
Cell Metab; 2017 Apr; 25(4):935-944.e4. PubMed ID: 28380381
[TBL] [Abstract][Full Text] [Related]
5. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
6. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
8. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
[TBL] [Abstract][Full Text] [Related]
10. FGF21 regulates insulin sensitivity following long-term chronic stress.
Jelenik T; Dille M; Müller-Lühlhoff S; Kabra DG; Zhou Z; Binsch C; Hartwig S; Lehr S; Chadt A; Peters EMJ; Kruse J; Roden M; Al-Hasani H; Castañeda TR
Mol Metab; 2018 Oct; 16():126-138. PubMed ID: 29980484
[TBL] [Abstract][Full Text] [Related]
11. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
[TBL] [Abstract][Full Text] [Related]
12. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
[TBL] [Abstract][Full Text] [Related]
14. Central Resistin/TLR4 Impairs Adiponectin Signaling, Contributing to Insulin and FGF21 Resistance.
Benomar Y; Amine H; Crépin D; Al Rifai S; Riffault L; Gertler A; Taouis M
Diabetes; 2016 Apr; 65(4):913-26. PubMed ID: 26740596
[TBL] [Abstract][Full Text] [Related]
15. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
[TBL] [Abstract][Full Text] [Related]
16. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
Dyck DJ; Heigenhauser GJ; Bruce CR
Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
[TBL] [Abstract][Full Text] [Related]
17. Potential roles of fibroblast growth factor 21 in the brain.
Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
[TBL] [Abstract][Full Text] [Related]
18. Perilipin 5 Deletion Unmasks an Endoplasmic Reticulum Stress-Fibroblast Growth Factor 21 Axis in Skeletal Muscle.
Montgomery MK; Mokhtar R; Bayliss J; Parkington HC; Suturin VM; Bruce CR; Watt MJ
Diabetes; 2018 Apr; 67(4):594-606. PubMed ID: 29378767
[TBL] [Abstract][Full Text] [Related]
19. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
20. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor.
Teillon S; Calderon GA; Rios M
J Endocrinol; 2010 Apr; 205(1):37-47. PubMed ID: 20097691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]